Jun 2026 (Q2 FY26) — Aug 6, 2026
U.S. Physical Therapy Q2 FY26 — Strong Volumes and Hospital Affiliation Ramp-Up
Read the full callU S Physical Therapy (USPH) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
U S Physical Therapy earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 214 | +8.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 10.3 | −2.4 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 9.9 | −20.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$83.91 −2.10% · −$1.8
Performance −5.6% 1Y
1Y: $88.93 on 17 Oct 2025 → $83.91. High $93.16 (24 Oct 2025), low $59 (7 May 2026).
- Previous close
- $85.71
- 52-week range
- $59 – $93.16
- One year
- −6.37%
Overview
- Symbol
- USPH
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
U S Physical Therapy earnings calls (USPH)
Financials
What the filings say
Net profit, year on year: −20% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 168 | 180 | 184 | 197 | 197 | 203 | 198 | 214 |
| Expenses | 139 | 148 | 153 | 156 | 160 | 163 | 166 | 172 |
| Operating profit | 13 | 15 | 20 | 25 | 25 | 17 | 12 | 22 |
| Operating margin | 7.7% | 8.1% | 10.7% | 12.6% | 12.8% | 8.3% | 6.3% | 10.3% |
| Other income | -1 | 4 | -2 | -2 | -2 | -2 | -2 | -3 |
| Profit before tax | 12 | 18 | 17 | 23 | 23 | 15 | 11 | 19 |
| Tax rate | 20.7% | 31.8% | 22.3% | 21.8% | 22.9% | 38.7% | 22.8% | 21.8% |
| Net profit | 7 | 9 | 10 | 12 | 13 | 4 | 5 | 10 |
| EPS ($ per share) | 0.39 | — | 0.80 | 0.58 | 0.48 | — | 0.12 | 0.25 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 167 | 184 | 212 | 224 | 233 | 224 | 227 | 227 |
| Total liabilities | 92 | 181 | 184 | 297 | 374 | 345 | 408 | 434 |
| Fixed assets | 20 | 22 | 22 | 23 | 25 | 26 | 32 | 36 |
| Total assets | 443 | 631 | 594 | 749 | 858 | 997 | 1,167 | 1,204 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 73 | 62 | 100 | 76 | 59 | 82 | 75 | 75 |
| Cash from investing | -24 | -38 | -51 | -124 | -81 | -45 | -149 | -37 |
| Cash from financing | -48 | -24 | -39 | 43 | 26 | 84 | -37 | -44 |
| Net cash flow | 1 | 0 | 9 | -4 | 3 | 121 | -111 | -6 |
| Capital expenditure | -7 | -10 | -8 | -8 | -8 | -9 | -9 | -14 |
| Free cash flow | 66 | 52 | 92 | 68 | 50 | 73 | 66 | 61 |
Insider filings
29 filings between Nov 20, 2025 and Oct 1, 2026.
Open market
decisions to buy or sellPurchases
$325.3K
5 purchases by 2 insiders
Sales
$498.6K
5 sales by 2 insiders
Compensation
not trading decisions- 12
- Award — granted as compensation
- 6
- Tax withheld — shares kept back by the company to cover tax
Also filed: 1 disposition to issuer.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Gilmartin Kathleen A | $276.0K | — | Nov 20, 2025 |
| REEVE GRAHAM D. | — | $253.7K | Mar 11, 2026 |
| Binstein Richard | — | $244.9K | Mar 6, 2026 |
| Minan Peter Francis | $49.3K | — | Sep 11, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Davis Myra Director | Award | 1,210 | $0 |
| Sep 14, 2026 | Etta Nchacha EVP & Chief Financial Officer | Award | 6,831 | $0 |
| Sep 11, 2026 | Minan Peter Francis Director | Purchase | 5 | $416 |
| Aug 20, 2026 | REEVE GRAHAM D. COO | Tax withheld | 762 | $59.4K |
| Aug 20, 2026 | Williams Eric Joseph President and COO | Tax withheld | 714 | $55.7K |
| Aug 20, 2026 | Binstein Richard EVP Gen'l Counsel & Secretary | Tax withheld | 450 | $35.1K |
| Aug 20, 2026 | CURTIS JASON TRAVIS Interim CFO | Tax withheld | 40 | $3.1K |
| Jun 12, 2026 | Minan Peter Francis Director | Purchase | 1 | $58 |
| Jun 9, 2026 | Minan Peter Francis Director | Purchase | 288 | $17.7K |
| Jun 8, 2026 | Minan Peter Francis Director | Purchase | 492 | $31.1K |
| May 20, 2026 | REEVE GRAHAM D. COO | Tax withheld | 762 | $47.4K |
| May 20, 2026 | CURTIS JASON TRAVIS Interim CFO | Tax withheld | 40 | $2.5K |
| May 19, 2026 | Swanson Regg E. Director | Award | 2,306 | $0 |
| May 19, 2026 | Minan Peter Francis Director | Award | 2,306 | $0 |
| May 19, 2026 | Motsenbocker Anne Director | Award | 2,306 | $0 |
| May 19, 2026 | Gilmartin Kathleen A Director | Award | 2,306 | $0 |
| May 19, 2026 | Harris Bernard A Jr Director | Award | 2,306 | $0 |
| Mar 11, 2026 | REEVE GRAHAM D. COO | Sale | 662 | $52.2K |
| Mar 9, 2026 | REEVE GRAHAM D. COO | Sale | 1 | $79 |
| Mar 9, 2026 | HENDRICKSON CAREY P Chief Financial Officer | Disposition to issuer | 10,000 | $0 |
| Mar 6, 2026 | REEVE GRAHAM D. COO | Sale | 1,807 | $148.6K |
| Mar 6, 2026 | Binstein Richard EVP Gen'l Counsel & Secretary | Sale | 3,000 | $244.9K |
| Feb 23, 2026 | READING CHRISTOPHER J Chairman of the Board and CEO | Award | 25,000 | $0 |
| Feb 23, 2026 | Williams Eric Joseph President and COO | Award | 15,000 | $0 |
| Feb 23, 2026 | REEVE GRAHAM D. COO | Award | 10,000 | $0 |
| Feb 23, 2026 | Binstein Richard EVP Gen'l Counsel & Secretary | Award | 10,000 | $0 |
| Feb 23, 2026 | HENDRICKSON CAREY P Chief Financial Officer | Award | 10,000 | $0 |
| Nov 24, 2025 | REEVE GRAHAM D. COO | Sale | 743 | $52.8K |
| Nov 20, 2025 | Gilmartin Kathleen A Director | Purchase | 4,000 | $276.0K |
| Sep 11, 2025 | HAM NANCY Director | Sale | 600 | $49.0K |
| Sep 5, 2025 | Williams Eric Joseph President and COO | Sale | 1,000 | $85.3K |
| Sep 4, 2025 | READING CHRISTOPHER J Chairman of the Board and CEO | Sale | 2,000 | $167.1K |
| Aug 25, 2025 | HENDRICKSON CAREY P Chief Financial Officer | Sale | 698 | $60.1K |
| Aug 21, 2025 | REEVE GRAHAM D. COO | Sale | 763 | $64.8K |
| Aug 19, 2025 | Binstein Richard EVP Gen'l Counsel & Secretary | Disposition to issuer | 2,000 | $169.6K |
| Aug 11, 2025 | REEVE GRAHAM D. COO | Sale | 1,792 | $155.1K |
| Jun 12, 2025 | HAM NANCY Director | Sale | 400 | $31.2K |
| May 21, 2025 | Williams Eric Joseph President and COO | Sale | 633 | $49.4K |
| May 21, 2025 | REEVE GRAHAM D. COO | Sale | 530 | $41.4K |
| May 20, 2025 | Swanson Regg E. Director | Award | 1,882 | $0 |
| May 20, 2025 | Harris Bernard A Jr Director | Award | 1,882 | $0 |
| May 20, 2025 | Gilmartin Kathleen A Director | Award | 1,882 | $0 |
| May 20, 2025 | Motsenbocker Anne Director | Award | 1,882 | $0 |
| May 20, 2025 | HAM NANCY Director | Award | 1,882 | $0 |
| May 20, 2025 | Trier Clayton Director | Award | 1,882 | $0 |
| Mar 11, 2025 | HENDRICKSON CAREY P Chief Financial Officer | Gift | 63 | $0 |
| Mar 7, 2025 | REEVE GRAHAM D. COO | Sale | 1,730 | $142.1K |
| Feb 24, 2025 | Binstein Richard EVP Gen'l Counsel & Secretary | Award | 8,100 | $0 |
| Feb 24, 2025 | READING CHRISTOPHER J Chairman of the Board and CEO | Award | 20,250 | $0 |
| Feb 24, 2025 | Williams Eric Joseph President and COO | Award | 12,150 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for U S PHYSICAL THERAPY INC /NV
Free account. Everything above stays public.
Write why you follow U S PHYSICAL THERAPY INC /NV and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading